SCHEMBL18159520

SCHEMBL18159520

O=[N+]([O-])c1ccccc1-c1ccc2c(c1)-c1ccccc1-c1ccccc1O2

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.53
TDP1 Q9NUW8 1/20 0.53
TP53 P04637 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
MAPK1 P28482 1/20 0.41
CYP2C19 P33261 1/20 0.41
STAT6 P42226 1/20 0.41
HIF1A Q16665 1/20 0.41
PHLPP2 Q6ZVD8 1/20 0.41
HSD17B10 Q99714 1/20 0.41
LMNA P02545 2/20 0.40
ADORA1 P30542 1/20 0.39
MAOB P27338 2/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
GSK3A P49840 2/20 0.39
GSK3B P49841 2/20 0.39
MAPT P10636 3/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17165540 0.88 ALDH1A1 (0.56) ALDH1A1TDP1TP53CYP1A2CYP3A4
SCHEMBL17065883 0.85 ALDH1A1 (0.50) ALDH1A1TDP1TP53CYP1A2CYP3A4
SCHEMBL17420850 0.82 ALDH1A1 (0.66) ALDH1A1TDP1TP53CYP1A2CYP3A4
SCHEMBL17065884 0.81 ALDH1A1 (0.49) ALDH1A1TDP1TP53CYP1A2CYP3A4
SCHEMBL17876505 0.81 ALDH1A1 (0.51) ALDH1A1TDP1LMNAADORA1MAOB
SCHEMBL16801198 0.78 ATM (0.47) ALDH1A1TDP1CYP1A2CYP2D6MAPK1
SCHEMBL25244348 0.78 ALDH1A1 (0.64) ALDH1A1TDP1TP53CYP1A2CYP3A4
SCHEMBL19651121 0.76 ALDH1A1 (0.62) ALDH1A1TDP1TP53CYP1A2CYP3A4
SCHEMBL16801273 0.76 KDM4E (0.45) ALDH1A1CYP1A2CYP2D6MAPK1LMNA
SCHEMBL18159635 0.76 KDM4E (0.45) ALDH1A1CYP1A2CYP2D6MAPK1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11917913-B2 Substituted oxepines MERCK PATENT GMBH (DE) 2024-02-27 US disclosed
US-20160308146-A1 SUBSTITUTED OXEPINES MERCK PATENT GMBH (DE) 2016-10-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11917913-B2 Substituted oxepines OXGR1, OXTR, OCIAD2 ALDH1A1 1740/4885TDP1 3230/4885TP53 2919/4885
US-20160308146-A1 SUBSTITUTED OXEPINES OXGR1, OXTR, OCIAD2 ALDH1A1 1740/4885TDP1 3230/4885TP53 2919/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.